NIH-funded research R21 grant

Targeting specific channels involved in pain sensation

Official title: Targeting Specific ASIC Subunits and Heteromers Using Protein Engineering

Funded at University of Rochester · NIH-11139251 · Data updated 2026-11-12

This study is exploring how certain proteins in our body that help us feel pain work, with the goal of finding new ways to create pain relief treatments for people who suffer from pain and related conditions.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startApril 1, 2025
Project endMarch 31, 2027
Funding year2025
Award (this year)$231,000
NIH project number1R21NS138705-01A1
Project IDNIH-11139251 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals experiencing chronic pain or conditions related to pain perception, such as neuropathic pain or inflammatory pain.

Less likely to help

Patients who do not experience pain or have conditions unrelated to pain sensation may not benefit from this research.

What this research studies

This research focuses on acid-sensing ion channels (ASICs), which play a crucial role in pain perception and various neurological conditions. By using protein engineering, the study aims to identify and target specific ASIC subunits that are involved in pain signaling. The approach includes investigating how these channels function in both humans and rodents, and how they can be manipulated to develop new analgesic treatments. The research seeks to overcome challenges in drug design by understanding the binding sites and mechanisms of these channels.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective pain relief treatments for patients suffering from various pain conditions.

How similar studies have gone: Previous research has shown promise in targeting ASIC channels for pain management, indicating that this approach could lead to significant advancements in treatment.

Where this research is happening

  • University of Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Maclean, David Malcom — University of Rochester
  • Study coordinator: Maclean, David Malcom

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.